- Home
- NN vs ANIP Comparison
NN vs ANIP Comparison
Compare NN & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NN
- ANIP
- Stock Information
- Founded
- NN 2007
- ANIP 2001
- Country
- NN United States
- ANIP United States
- Employees
- NN N/A
- ANIP N/A
- Industry
- NN Industrial Machinery/Components
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- NN Industrials
- ANIP Health Care
- Exchange
- NN Nasdaq
- ANIP Nasdaq
- Market Cap
- NN 1.9B
- ANIP 2.0B
- IPO Year
- NN N/A
- ANIP N/A
- Fundamental
- Price
- NN $12.35
- ANIP $90.06
- Analyst Decision
- NN
- ANIP Strong Buy
- Analyst Count
- NN 0
- ANIP 7
- Target Price
- NN N/A
- ANIP $99.14
- AVG Volume (30 Days)
- NN 1.4M
- ANIP 347.5K
- Earning Date
- NN 11-06-2025
- ANIP 11-07-2025
- Dividend Yield
- NN N/A
- ANIP N/A
- EPS Growth
- NN N/A
- ANIP N/A
- EPS
- NN N/A
- ANIP 1.76
- Revenue
- NN $5,539,000.00
- ANIP $826,880,000.00
- Revenue This Year
- NN N/A
- ANIP $40.23
- Revenue Next Year
- NN N/A
- ANIP $9.65
- P/E Ratio
- NN N/A
- ANIP $51.34
- Revenue Growth
- NN 11.61
- ANIP 48.87
- 52 Week Low
- NN $9.05
- ANIP $52.50
- 52 Week High
- NN $18.54
- ANIP $99.50
- Technical
- Relative Strength Index (RSI)
- NN 41.64
- ANIP 43.48
- Support Level
- NN $11.34
- ANIP $89.47
- Resistance Level
- NN $12.72
- ANIP $95.57
- Average True Range (ATR)
- NN 0.77
- ANIP 4.08
- MACD
- NN 0.01
- ANIP -0.30
- Stochastic Oscillator
- NN 44.87
- ANIP 62.24
About NN NextNav Inc.
NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation, and Timing services in the absence of GPS.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.